
Every system is perfectly designed to get the results it gets.
“Every system is perfectly designed to get the results it gets.” – W. Edwards Deming For years, it has been well understood that excessive sedation

“Every system is perfectly designed to get the results it gets.” – W. Edwards Deming For years, it has been well understood that excessive sedation

Acute Respiratory Distress Syndrome (ARDS) is a life-threatening condition characterized by severe lung inflammation and difficulty maintaining normal oxygen levels. It accounts for approximately 25%

Somnus’ CEO Dr Tim Craft was recently in the USA speaking at theAnnual Conference of the Society for Technology in Anaesthesia (STA). We asked him

The phrase “First Do No Harm” is a Latin quote (Primum non nocere) often (though with little evidence) attributed to Hippocrates and applied to an

Propofol is the first-line sedative recommended for patients in ICU, especially those needing help with their breathing from a ventilator. The challenge is that it

For years, midazolam (a benzodiazepine) was the preferred drug to be used with patients requiring sedation on ICU. More recently, though, numerous studies have been

Somnus is developing rapid, point-of-care propofol measuring technologies but is there another drug that could be used instead? Traditionally, benzodiazepines such as midazolam were the

The first report from Baroness Hallett, who is chairing the Covid public inquiry, has been published. In it she says, “it is not a question

Clinicians at the Institute of Liver and Biliary Sciences, Delhi, India have published the findings of their prospective study aimed at determining the target concentration

Somnus has developed the first ever antibody for propofol. This means that it will soon be possible to measure propofol in real time and optimise
Somnus is also a Scale-Up member of SETSquared.
Somnus Scientific Ltd
Stockland
Beechen Cliff Rd
Bath
BA2 4QR